P 390 5 Apr 358.20 380 370 360 350 28
P 5
The share price of Nasdaq-listed Achilles Therapeutics, a portfolio company of
(c) 2024 City A.M., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
464 GBX | +1.49% | +8.82% | -0.13% |
May. 09 | NatWest target raised, other lenders backed | AN |
May. 08 | OSB hails first-quarter performance; set to meet guidance | AN |
P 390 5 Apr 358.20 380 370 360 350 28
P 5
The share price of Nasdaq-listed Achilles Therapeutics, a portfolio company of
(c) 2024 City A.M., source
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
464 GBX | +1.49% | +8.82% | 2.28B | ||
126.5 GBX | +1.20% | +2.85% | 194M | ||
120.8 GBX | -0.49% | +0.33% | 986M | ||
1st Jan change | Capi. | |
---|---|---|
-0.13% | 2.28B | |
-8.09% | 84.79B | |
-10.23% | 20.39B | |
+12.85% | 14.41B | |
+37.94% | 8.47B | |
-9.28% | 6.84B | |
+5.59% | 4.75B | |
+16.86% | 4.13B | |
-11.86% | 3.3B | |
+0.54% | 2.78B |